Fusivac B Cream is a topical medication formulated with Beclometasone (0.10% w/w) and Fusidic Acid (0.2% w/w), designed to effectively treat inflammatory skin conditions complicated by bacterial infections. Beclometasone, a potent corticosteroid, works by reducing inflammation, redness, and itching, providing symptomatic relief in conditions such as eczema, dermatitis, and psoriasis. Fusidic Acid, a bacteriostatic antibiotic, targets and inhibits the growth of susceptible bacteria, particularly Staphylococcus aureus, thereby preventing or treating secondary bacterial infections that often accompany inflammatory skin disorders. The combination of these two active ingredients allows Fusivac B Cream to address both inflammation and infection simultaneously, promoting faster healing and improved skin condition. It is typically applied in a thin layer to the affected area once or twice daily, as directed by a healthcare professional. Fusivac B Cream should be used with caution in patients with a history of hypersensitivity to corticosteroids or fusidic acid, and prolonged use should be avoided to minimize potential side effects such as skin thinning or antibiotic resistance. This cream is suitable for adults and children under medical supervision and should not be applied to open wounds or mucous membranes. Overall, Fusivac B Cream is an effective dual-action treatment for managing inflamed, infected skin lesions.